ZBIO

Zenas BioPharmaA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

ZBIO vs peer average

88/100

ZBIO vs. peer average (A vs. C)

Grade spread

B 3 · C 1 · D 2 · F 2

Graded peers loaded

Coverage

8 graded

100% of tracked

Peer overview

AGIO is the first available peer comparator.

Loose same-sector market-cap biotech comparison; useful for development-stage risk framing but not a direct autoimmune or regulatory analog.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAGIOAgios

ZBIO

Zenas BioPharma

AGIO

Agios

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs AGIO

ZBIO / AGIO

Grade Position

Above peers

ZBIO vs. peer average (A vs. C)

88/100

Momentum

ZBIO

Value

ZBIO

Sentiment

ZBIO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ZBIO

20/100

80/100

80/100

Taysha Gene Therapies Inc Common

60/100

KARD

Kardigan Inc Common

20/100

AGIO is the first peer returned for this comparison set.